DSIP and Semax get grouped together often enough in peptide-stack conversations that it’s easy to assume they do similar things. They don’t — one is researched specifically for sleep architecture, the other for cognitive and mood-adjacent pathways.
What DSIP Targets
Delta sleep-inducing peptide (DSIP) is researched specifically around sleep architecture, particularly delta-wave (deep) sleep. For perimenopausal sleep disruption — one of the most commonly reported symptoms in this life stage — this is the more directly relevant of the two compounds.
What Semax Targets
Semax’s research profile centers on cognitive function and neuroprotection, with interest in BDNF (brain-derived neurotrophic factor) pathway modulation. It’s researched more in brain-fog and mood-regulation contexts than sleep specifically, though better mood regulation can indirectly support sleep quality.
Choosing Based on Your Primary Complaint
If sleep itself is the primary disruption, DSIP’s mechanism is more directly targeted. If brain fog or mood swings are the dominant symptom and sleep is a secondary concern, Semax’s cognitive-focused research may be more relevant. They’re not mutually exclusive, but starting with the one matching your primary complaint makes it easier to evaluate.
Sourcing
Both are available for research purposes through the following vendor.